Central venous catheter as vascular approach for hemodialysis - our experiences.

Central venous catheter as vascular approach for hemodialysis - our experiences.
复制标题

DOI:
10.5455/msm.2015.27.112-113
复制
发表时间:
2015-04-01
期刊:
Materia socio-medica
影响因子:
--
通讯作者:
Rahmanovic, Samra
Rahmanovic, Samra
中科院分区:
其他
文献类型:
--
作者:
Misanovic, Verica;Jonuzi, Fedzat;Rahmanovic, Samra

文献摘要

被引文献

相似文献

简介:中心静脉导管(CVC)作为血液透析的临时或永久血管通路的应用,一直在萨拉热窝儿科诊所的儿科重症监护室不断实践。本文的主要目的是介绍我们使用中心静脉导管治疗这些患者的经验。 材料和方法:2009 年 1 月至 2014 年 12 月期间,总共治疗了 41 名患者,总共放置了 56 根导管。 结果:结果显示股静脉导管的普及率 (69.64%),颈静脉导管 (28.57%) 和静脉导管的参与明显较少。锁骨下导管的象征性参与(1.78%)。我们文章中的感染频率为 8.92%,低于国家医院感染监测系统数据中包含的百分比,该系统提供了 17% 的导管相关感染的数据。我们患者中最常见的导管相关感染病原体是肺炎克雷伯菌组的革兰氏阴性菌。结论:治疗期间较高的并发症百分比问题与 28.57% 患者的导管内或周围出血相关的止血有关,以及 10.71% 的患者与血栓形成相关的凝血障碍有关。
INTRODUCTION: Application of a central venous catheter (CVC), as a temporary or permanent vascular access for hemodialysis, has been continuous practice at the Sarajevo Pediatric Clinic, Department of Pediatric Intensive Care. The main goal of the article is to present our experiences with central venous catheters in the treatment of these patients.MATERIAL AND METHODS: In the period from January 2009 to December 2014 a total of 41 patients were treated and a total of 56 catheters were placed.RESULTS: The results show the prevalence of the femoral venous catheter (69,64%), with significantly smaller participation of jugular (28,57%) and symbolic participation of subclavian catheters (1,78%). Frequency of infections of 8,92% in our article is lower than the percentage contained in the data of the National Nosocomial Infections Surveillance System, which provided data related to 17% of catheter related infections. The most common agents of the catheter related infections in our patients are gram-negative bacteria from the Klebsiella pneumoniae group.CONCLUSION: The issue of the higher complication percentage during the treatment is linked with hemostasis related to bleeding into or around the catheters in 28,57% of patients, and to clotting disorder in terms of thrombosis in 10,71% of patients.